Citalopram - NDSRI's
References
FAQ's
References
- Boegesoe, Klaus Peter; Toft, Anders Stausboell, Anti-depressive substituted 1-dimethylaminopropyl-1-phenyl phthalans, Kefalas A/S, Denmark, US4136193A, January 23, 1979
- Overoe, Kerstin Fredricson, Fluorescence assay of citalopram and its metabolites in plasma by scanning densitometry of thin-layer chromatograms, Journal of Chromatography, Biomedical Applications, Volume: 224, Issue: 3, Pages: 526-31, 1981
Frequently Asked Questions
What are the regulatory requirements for Citalopram impurities?
Regulatory requirements for impurities in Citalopram are described in various pharmacopeias and regulatory guidelines such as ICH and USP.
What are the types of Citalopram impurities?
The types of impurities in Citalopram include related substances, residual solvents, and inorganic impurities.
Which solvent helps in the analysis of Citalopram impurities?
Acetonitrile or Methanol are the solvents used in analyzing many impurities in Citalopram.
What are the temperature conditions required to store Citalopram impurities?
Citalopram impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.